Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Structure and Function of Leukocytes01:21

Structure and Function of Leukocytes

An adult in good health typically has between 4,500 and 11,000 leukocytes, or white blood cells, per microliter of blood, which constitutes about 1% of the total blood volume. Unlike red blood cells, white blood cells contain a nucleus and other cellular organelles but do not have hemoglobin. Most white blood cells reside in connective tissues, particularly in lymphatic organs such as the lymph nodes, with only a small fraction present in circulating blood.
White blood cells protect the body...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203.

Leukemia·2025
Same author

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms.

Leukemia·2023
Same author

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.

Blood cancer journal·2021
Same author

Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal.

Blood·2021
Same author

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2021
Same author

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2021

Video Experimental Relacionado

Updated: Jul 17, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

La leucemia mieloide aguda es una leucemia mieloide aguda.

Elihu Estey1, Hartmut Döhner

  • 1Leukemia Department, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA. ehestey@mdanderson.org

Lancet (London, England)
|November 28, 2006
PubMed
Resumen

La leucemia mieloide aguda (LMA) es un cáncer común en adultos. Los defectos genéticos afectan los resultados del tratamiento de la LMA, con pacientes de edad avanzada que enfrentan malos pronósticos a pesar de los avances en terapias dirigidas.

Más Videos Relacionados

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Videos de Experimentos Relacionados

Last Updated: Jul 17, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Área de la Ciencia:

  • Hematología Hematología.
  • Oncología Oncología.
  • Biología Molecular Biología Molecular

Sus antecedentes:

  • La leucemia mieloide aguda (LMA) es un trastorno mieloide maligno prevalente en adultos, generalmente diagnosticado alrededor de los 70 años.
  • Las mutaciones genéticas son determinantes clave de la respuesta a la quimioterapia y los resultados del paciente en la LMA.
  • Existe un progreso significativo en el tratamiento para los adultos más jóvenes, pero los pacientes de edad avanzada experimentan tasas de supervivencia desalentadoras debido a las comorbilidades y la biología de la enfermedad.

Objetivo del estudio:

  • Revisar la comprensión actual de la patogénesis de la LMA, centrándose en los factores genéticos.
  • Para resaltar los desafíos en el tratamiento de pacientes ancianos con LMA.
  • Discutir el potencial de las terapias dirigidas para mejorar las tasas de curación de la LMA.

Principales métodos:

  • Revisión de la investigación reciente de biología molecular en LMA.
  • Análisis de los resultados del tratamiento comparando diferentes grupos de edad.
  • Evaluación de los enfoques emergentes de terapia dirigida.

Principales resultados:

  • Los defectos genéticos son cruciales en la progresión de la LMA y la respuesta al tratamiento.
  • Los pacientes ancianos con LMA tienen un mal pronóstico en comparación con los individuos más jóvenes.
  • Las terapias dirigidas representan una vía prometedora para aumentar las tasas de curación de la LMA.

Conclusiones:

  • Comprender la patogénesis molecular de la LMA es vital para desarrollar tratamientos efectivos.
  • Abordar los factores relacionados con la edad y la biología de la enfermedad es esencial para mejorar los resultados de los pacientes ancianos.
  • Las terapias dirigidas tienen una promesa significativa para mejorar la eficacia del tratamiento de la LMA y las tasas de supervivencia.